Display options
Cite
Ghabril M, Dickson RC, Krishna M, et al. Persistence of hepatitis C RNA in liver allografts is associated with histologic progression independent of serologic viral clearance. J Transplant. 2009;2009:297528doi: 10.1155/2009/297528.
Ghabril, M., Dickson, R. C., Krishna, M., Lloyd, R., Aranda-Michel, J., Keaveny, A., Satyanarayana, R., & Bonatti, H. (2009). Persistence of hepatitis C RNA in liver allografts is associated with histologic progression independent of serologic viral clearance. Journal of transplantation, 2009297528. https://doi.org/10.1155/2009/297528
Ghabril, M, et al. "Persistence of hepatitis C RNA in liver allografts is associated with histologic progression independent of serologic viral clearance." Journal of transplantation vol. 2009 (2009): 297528. doi: https://doi.org/10.1155/2009/297528
Ghabril M, Dickson RC, Krishna M, Lloyd R, Aranda-Michel J, Keaveny A, Satyanarayana R, Bonatti H. Persistence of hepatitis C RNA in liver allografts is associated with histologic progression independent of serologic viral clearance. J Transplant. 2009;2009:297528. doi: 10.1155/2009/297528. Epub 2009 May 05. PMID: 20107579; PMCID: PMC2809420.
Copy Download .nbib Format: NLM
Share it on

J Transplant. 2009;2009:297528. doi: 10.1155/2009/297528. Epub 2009 May 05.

Persistence of hepatitis C RNA in liver allografts is associated with histologic progression independent of serologic viral clearance.

Journal of transplantation

M Ghabril, R C Dickson, M Krishna, R Lloyd, J Aranda-Michel, A Keaveny, R Satyanarayana, H Bonatti

Affiliations

  1. Department of Gastroenterology and Hepatology, Clarian/Indiana University School of Medicine, 975 W Walnut Street 1B327, Indianapolis, IN 46202-5181, USA.

PMID: 20107579 PMCID: PMC2809420 DOI: 10.1155/2009/297528

Abstract

Background. Hepatitis C virus (HCV) nondetectability in the liver may predict a sustained viral response (SVR) in patients with an end of treatment response. HCV RNA can be detected in liver tissue by in situ hybridization (ISH). Aim. To determine if HCV nondetectability in liver allografts by ISH can predict SVR in patients who cleared virus serologically on treatment. Methods. Twenty five patients with undetectable serum HCV on Interferon/Ribavirin therapy for HCV recurrence post liver transplant (LT) were studied. All had biopsies at 4 months post LT (baseline) and follow up with HCV ISH analysis performed. Results. 10 were ISH positive (group 1); 15 were ISH negative (group 2). Groups 1 and 2 had similar patient, donor, and viral characteristics at LT, as well as treatment duration at the time of the ISH assayed liver biopsy (13 +/- 16 versus 10 +/- 4 months P = .24). However, group 1 had longer total treatment duration (24 +/- 10 versus 14 +/- 5 months, P = .001). Eight (80%) group 1 and 9 (60%) group 2 patients achieved SVR. Mean grade and stage (modified Ishak score) were similar at 4 months, however, group 1 had higher grade (3 +/- 1.7 versus 1.6 +/- 1.3, P = .039) and stage (1.4 +/- 1.4 versus 0.5 +/- 0.6, P = .084) on the ISH assayed biopsy, after similar post LT intervals (23 +/- 10 versus 24 +/- 12 months, P = .91). Conclusion. Allograft HCV ISH nondetectability does not predict SVR in treatment responsive HCV recurrence, but is associated with less severe histologic disease.

References

  1. Am J Transplant. 2005 Aug;5(8):1909-13 - PubMed
  2. Gastroenterology. 2006 Jul;131(1):76-84 - PubMed
  3. Ann Intern Med. 1995 Apr 15;122(8):586-91 - PubMed
  4. Am J Gastroenterol. 2002 Oct;97(10):2614-8 - PubMed
  5. Hepatology. 2008 Jan;47(1):43-50 - PubMed
  6. Hepatology. 2005 Jan;41(1):106-14 - PubMed
  7. Hepatology. 1999 Jan;29(1):223-9 - PubMed
  8. Liver Transpl. 2004 May;10(5):595-8 - PubMed
  9. Gastroenterology. 2006 Apr;130(4):1086-97 - PubMed
  10. Liver Transpl. 2004 Feb;10(2):199-207 - PubMed
  11. Diagn Mol Pathol. 2004 Mar;13(1):9-14 - PubMed
  12. Am J Transplant. 2007 Feb;7(2):448-53 - PubMed
  13. J Infect Dis. 2008 Feb 1;197(3):355-60 - PubMed
  14. J Virol. 2006 Mar;80(5):2280-90 - PubMed
  15. Liver Transpl. 2002 Oct;8(10 Suppl 1):S14-8 - PubMed
  16. J Virol. 2000 Jan;74(2):944-55 - PubMed
  17. Hum Pathol. 2002 Mar;33(3):277-84 - PubMed
  18. Liver Transpl. 2007 Aug;13(8):1137-44 - PubMed
  19. J Hepatol. 1995 Jun;22(6):696-9 - PubMed

Publication Types